Products for Out-licensing
Partner with Eurand in the Lifecycle Management of your product portfolio
Eurand has a portfolio of Rx and OTC products available for licensing. In general, these products are new formulations of existing drugs that incorporate one or more of our proprietary drug delivery technologies.
We license these products to pharmaceutical companies for marketing throughout the world. Some of those available for out-licensing are detailed below.
Click on your product of interest for additional details. For more information, please contact us at partners@eurand.com.
| Therapeutic Category | Product Name | Eurand Technology |
|---|---|---|
 Cardiovascular |
Diltiazem (once daily) 120 mg, 180 mg, 240 mg, 300 mg Sustained-Release Capsules |
Diffucaps® |
| Nifedipine (once daily) 30 mg, 60 mg Sustained-Release Capsules |
Eurand Minitabs® | |
| Potassium chloride 8 mEq (600 mg) – 10 mEq (750 mg), 20 mEq (1500 mg) |
Microcaps® | |
 Sleep Aid |
Temazepam 7.5 mg, 15 mg, 22.5 mg, 30 mg Orally Disintegrating Tablets |
AdvaTab® |
| Diphenhydramine HCl 25 mg Orally Disintegrating Tablet |
AdvaTab® | |
 Gastroenterology |
EUR-1008 (Ex-U.S.) Broad range of dosage strengths available |
Enteric-coated beads |
| Paraffin Oil + Psyllium 10 g sachet (equal parts paraffin, psyllium, and excipients) |
Microcaps® | |
 Nutrition |
Vitamin C (once daily) 500 mg sustained-release capsules also available from 60 mg – 500 mg as food product |
Diffucaps® |
| Vitamin C 300 mg / zinc 5 mg Combination Food Product |
Diffucaps® | |
 Pain |
Cyclobenzaprine HCl (once daily) 15 mg, 30 mg Extended-Release Capsules |
Diffucaps® |
| Ibuprofen 200 mg Orally Disintegrating Tablets |
Microcaps® Ziplet® |
|
| Paracetamol 250 mg, 500 mg Orally Disintegrating Tablets |
AdvaTab® Microcaps® |
|
| Sodium diclofenac 75 mg, 100 mg Sustained-Release Capsules |
Diffucaps® | |
 Respiratory |
Theophylline 125 mg, 250 mg, 375 mg, 500 mg Sustained-Release Capsules |
Microcaps® |
This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.
